Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- PMID: 30597050
- DOI: 10.1093/infdis/jiy746
Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Keywords: CMV DNAemia; CMV-specific CD8+ T cells; Cytomegalovirus (CMV); allogeneic hematopoietic stem cell transplantation (allo-HSCT); immunological monitoring; preemptive antiviral therapy.
Comment in
-
Reply to Giménez et al.J Infect Dis. 2019 Apr 16;219(9):1512-1513. doi: 10.1093/infdis/jiy687. J Infect Dis. 2019. PMID: 30496440 Free PMC article. No abstract available.
Comment on
-
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.J Infect Dis. 2019 Feb 23;219(6):898-907. doi: 10.1093/infdis/jiy592. J Infect Dis. 2019. PMID: 30295846 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
